Author: admin
Precision CEO Matt Kane Discusses the Unique Features of ARCUS With PMWC
On January 22nd 2018, Precision BioSciences CEO and Co-founder Matt Kane will participate in the Silicon Valley Precision Medicine World Conference (PMWC), sharing his insights as part of...
Precision PlantSciences Helps Establish Vision and Goals for Crops of the Future Collaborative
DURHAM, North Carolina, USA, September 19 2017 – President of Precision PlantSciences, Fayaz Khazi, Ph.D., joined the other founding partners of the Crops of the Future (COTF) collaborative in...
David Thomson Joins Precision BioSciences as Chief Development Officer
DURHAM, North Carolina, USA, July 10 2017 – Precision BioSciences is pleased to welcome David Thomson, Ph.D., into a newly created position of Chief Development Officer. At Precision, David will...
Precision PlantSciences partners with Bayer, BioGemma, KWS, FAPESP, Rijk Zwaan and CIMMYT through the FFAR Crops of the Future Collaborative
DURHAM, North Carolina, USA, June 29, 2017 – Precision PlantSciences has signed on to a new initiative supported by the 2014 Farm Bill and run through the non-profit organization the Foundation...
Precision BioSciences Welcomes Fayaz Khazi, Ph.D. as President of PlantSciences
DURHAM, North Carolina, USA, June 16, 2017 – Precision BioSciences has appointed Fayaz Khazi, Ph.D., to serve as the President of Precision PlantSciences, a business unit developing innovative,...
Baxalta and Precision BioSciences form Global Genome Editing Collaboration in Immuno-Oncology
BANNOCKBURN, Ill. and DURHAM, North Carolina, February 25, 2016 – Baxalta Incorporated (NYSE: BXLT), a global biopharmaceutical leader dedicated to delivering transformative therapies to patients...
Precision BioSciences Announces Appointment of Gene Liau, Ph.D. and Bruce McCreedy, Ph.D. to Management Team
RESEARCH TRIANGLE PARK, North Carolina, September 2nd, 2015 – Precision BioSciences, the genome editing company, today announced two key additions to the executive team – Gene Liau, Ph.D., as...
Precision BioSciences Announces $25.6 Million Series A Financing
RESEARCH TRIANGLE PARK, North Carolina, May 11, 2015 – Precision BioSciences, the genome editing company, today announced the closing of a $25.6 million Series A financing led by venBio. Joining in...